US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist
  • 2.530
  • +0.090+3.69%
Close Dec 23 16:00 ET
  • 2.540
  • +0.010+0.40%
Post 16:04 ET
4.06MMarket Cap-0.14P/E (TTM)

About Silexion Therapeutics Company

Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.

Company Profile

SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005
Websitehttps://www.silexion.com

Company Executives

  • Name
  • Position
  • Salary
  • Ilan Hadar
  • Chairman of the Board and Prospective Chief Executive Officer
  • 253.61K
  • Mirit Horenshtein Hadar
  • Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
  • 26.24K
  • Dr. Mitchell Shirvan
  • Chief Scientific and Development Officer
  • 206.80K
  • Professor Amnon Peled, PhD
  • Independent Director
  • --
  • Ruth Alon
  • Independent Director
  • --
  • Shlomo Noy
  • Independent Director
  • --
  • Ilan Levin
  • Independent Director
  • --
  • Dror J. Abramov
  • Independent Director
  • --
  • Avner Lushi
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data